Lian Li
Qingpu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Targeting the TRIM25-AGO2-miR-148b-5p-ABCC1 axis overcomes chemoresistance in non-small cell lung cancer.
Journal: Cell death & disease
Published: October 20, 2025
SUMOylation of SND1 drives mature miRNA degradation and tumor progression.
Journal: Cancer letters
Published: September 10, 2025
Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 12, 2025
A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway.
Journal: Neoplasia (New York, N.Y.)
Published: September 15, 2024
The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs.
Journal: Nucleic acids research
Published: June 24, 2024
Loss of Fbxo45 in AT2 cells leads to insufficient histone supply and initiates lung adenocarcinoma.
Journal: Cell death and differentiation
Published: June 14, 2024
Leisure Activity, Childhood Starvation, and Risk of Incident Diabetes in Older Adults: Evidence from a Chinese Nationwide Cohort Study.
Journal: Journal of the American Medical Directors Association
Published: February 17, 2024
N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.
Journal: Cellular and molecular life sciences : CMLS
Published: October 11, 2023
Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 09, 2023
PTEN-mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.
Journal: Molecular oncology
Published: June 19, 2023
Last Updated: 09/26/2026